The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Dosing & titration

Titrating on tolerability rather than on the calendar — the long version

MD
m.dumitruTL213 Oct 2024#1

Titrating on tolerability rather than on the calendar — the long version Writing it up because I had to work it out twice and would rather nobody else did.

A narrow question about Titrating on tolerability, deliberately narrow, because the broad version has been asked here four times and produced four long threads and no answer.

One question, stated units, stated method, and what I have already ruled out.

10 likes 21mo
OA
o.abrahamsenTL3Regular6 Jan 2025#2

Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The published trials used a calendar-based schedule. Tolerability-based escalation has no formal evidence base but is not uncommon in practice.

I would put this at better than even and not much better.

0 likes 19mo
RM
r.molnarTL27 Mar 2025#3
o.abrahamsen, post #2: Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The published trials used a calendar-based schedule. Tolerability-based escalation has no formal evidence base but is not uncommon in practice. I would put this at better than… Go to post

Grateful for the specificity. Vague answers to this question are what sent me looking.

29 likes in reply to #2 17mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Escalating every six weeks instead of four: what I observed over eight months
Escalating every six weeks instead of four: what I observed over eight months Writing it up because I had to work it out twice and would rather nobody else did. Asking about escalating every six weeks instead…
RMKCCLHETP+27 31 432 18mo
Holding a dose indefinitely: is there a documented downside?
Holding a dose indefinitely: is there a documented downside? — that is the question, and I have not found it answered plainly anywhere I have looked. I have read the maintained page on this and I still have a…
HFOBRSPPBD+28 32 57k 12mo
Revisiting: The arithmetic of an intermediate dose between two label steps
Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
CSRHGBWTMR+41 45 808 2mo
What steady state means for the decision to escalate
What steady state means for the decision to escalate — that is the question, and I have not found it answered plainly anywhere I have looked. A question about steady state that I think has a definite answer,…
LWPADMHKM+31 35 2k 1d
Stepping down deliberately, and how to do it without losing progress
Stepping down deliberately, and how to do it without losing progress — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how…
EFCCBKEM+98 102 26k 3mo

Related topics — sharing the tags worked example, missed dose, titration

TopicParticipantsRepliesViewsActivity
SURPASS-2 and the comparator dose question that will not go away — what changed since
Posting this under the heading it deserves: SURPASS-2 and the comparator dose question that will not go away — what changed since Everything below is what sits behind that. What changes if the standard…
RIPREAGTMM+2 6 5.5k 7h
Escalating every six weeks instead of four: what I observed over eight months
Escalating every six weeks instead of four: what I observed over eight months Writing it up because I had to work it out twice and would rather nobody else did. Asking about escalating every six weeks instead…
RMKCCLHETP+27 31 432 18mo
Leak-back after withdrawal and whether you lost a meaningful dose
Posting this under the heading it deserves: Leak-back after withdrawal and whether you lost a meaningful dose Everything below is what sits behind that. I have read the maintained page on this and I still…
SDJPB 2 3k 3h
Second pass at: Albumin binding and how it produces a long half-life
Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. A narrow question about Albumin binding,…
BRIJVPYR+7 11 31k 17mo
Tirzepatide molecular mass and the charge states you would expect on ESI — does this still hold?
Asking directly, because I could not find a straight answer: Tirzepatide molecular mass and the charge states you would expect on ESI — does this still hold? The question about Tirzepatide molecular mass that…
TTARHMKRMC+7 11 281 6mo